RE:RE:RE:RE:RE:RE:RE:DR DR - PART TIME CEO?the ceo needs to deliver. i am very happy she landed chiasi as this valiates the platform and brings a big pharma onboard to drive the ship. again, not to repeat myself, but this is a platform technology. bioaf does not have to do much work at this point (well, not entirely true) aside from shoping this technology around to big pharma. if they like it, like chiasi did, then we sign a deal with upfront payments, royalties and milestones and big pharma will run the show. that is great because they have the resources and know how to do it. this technology could conceivably be used in conjunction with so many drugs. can you imagine how many deals we could announce? and what makes this even better is that even if some of these trials fail, the company can still succees big time. bioaf is not a one drug boom or bust. however, the ceo needs to show that more deals can be signed. if the technology is there then we should get them soon. JD, you probably have more insight to this than i do so i am hoping you are right when you say things are about to get interesting...more to come. based on the ceo's comments, we should be hearing more before the end of the year